| RS1304109530 |
ATP8A2
|
Health Risk |
Pathogenic |
Cerebellar ataxia, intellectual disability |
| RS1304119807 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS1304131217 |
CTNNA1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS1304140510 |
COL12A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS1304146232 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1304160279 |
CA2
|
Health Risk |
Likely pathogenic |
Osteopetrosis with renal tubular acidosis, Osteopetrosis with renal tubular acidosis |
| RS1304172230 |
CNGA1
|
Health Risk |
Pathogenic |
— |
| RS1304183009 |
GRM6
|
Health Risk |
Likely pathogenic |
Congenital stationary night blindness 1B, Congenital stationary night blindness 1B |
| RS1304201852 |
PTH1R
|
Health Risk |
Pathogenic |
Chondrodysplasia Blomstrand type, Chondrodysplasia Blomstrand type |
| RS1304218104 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1304228309 |
PCDH15
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 1F, Autosomal recessive nonsyndromic hearing loss 23 |
| RS1304244536 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotopia, periventricular |
| RS1304251276 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1304277420 |
GLB1
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-B |
| RS1304291054 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 1 |
| RS1304300872 |
KCNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 26 |
| RS1304320833 |
TMEM216
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Joubert syndrome 2 |
| RS1304351755 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS1304362773 |
ASXL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1304382790 |
DYNLT2B
|
Health Risk |
Pathogenic |
— |
| RS1304394441 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Adult hypophosphatasia, Hypophosphatasia |
| RS1304410089 |
DSP
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Arrhythmogenic right ventricular dysplasia 8 |
| RS1304418053 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal dominant 2 |
| RS1304421147 |
CLN5
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis 5 |
| RS1304422857 |
UBE3B
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Oculocerebrofacial syndrome |
| RS1304430926 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1304430967 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS1304441113 |
ELN
|
Health Risk |
Conflicting classifications of pathogenicity |
ELN-related disorder, ELN-related disorder |
| RS1304446470 |
NHEJ1
|
Health Risk |
Pathogenic |
Cernunnos-XLF deficiency, Cernunnos-XLF deficiency |
| RS1304451467 |
TYR
|
Health Risk |
Likely pathogenic |
SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN |
| RS1304454699 |
POLK
|
Health Risk |
Pathogenic |
Prostate cancer, Prostate cancer |
| RS1304456183 |
SLC17A5
|
Health Risk |
Pathogenic |
Salla disease, Salla disease |
| RS1304467714 |
TMEM43
|
Health Risk |
Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 5, Arrhythmogenic right ventricular dysplasia 5 |
| RS1304504006 |
DNAH5
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS1304506273 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1304533019 |
DNAAF1
|
Health Risk |
Likely pathogenic |
DNAAF1-related disorder, DNAAF1-related disorder |
| RS1304534644 |
SLC26A3
|
Health Risk |
Likely pathogenic |
SLC26A3-related disorder, SLC26A3-related disorder |
| RS1304560157 |
SQSTM1
|
Health Risk |
Likely pathogenic |
Neurodegeneration with ataxia, dystonia |
| RS1304570979 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS1304588947 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS1304629512 |
TRAF3IP2
|
Health Risk |
Pathogenic |
Candidiasis, familial |
| RS1304634005 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lynch syndrome 4, Hereditary cancer-predisposing syndrome |
| RS1304635321 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS1304643689 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1304645785 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS1304648449 |
SETD5
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1304655615 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1304667430 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1304669003 |
CBS
|
Health Risk |
Pathogenic/Likely pathogenic |
Classic homocystinuria, Homocystinuria |
| RS1304689724 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS1304694234 |
LIG4
|
Health Risk |
Pathogenic |
DNA ligase IV deficiency, DNA ligase IV deficiency |
| RS1304695155 |
HNF1B
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1304701232 |
PRKCG
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 14, Spinocerebellar ataxia type 14 |
| RS1304706298 |
TARDBP
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 10, FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS |
| RS1304713296 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia, Hereditary spastic paraplegia |
| RS1304714042 |
PCCB
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1304742332 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1304756557 |
ACTL6B
|
Health Risk |
Likely pathogenic |
ACTL6B-related BAFopathy, ACTL6B-related BAFopathy |
| RS1304758484 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS1304770743 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS1304787573 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1304795371 |
PSMB8
|
Health Risk |
Conflicting classifications of pathogenicity |
Proteosome-associated autoinflammatory syndrome, Inborn genetic diseases |
| RS1304802474 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1304809213 |
FANCM
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1304811464 |
CNGA1
|
Health Risk |
Pathogenic |
— |
| RS1304822359 |
PHIP
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS1304832284 |
ATP8A2
|
Health Risk |
Likely pathogenic |
Cerebellar ataxia, intellectual disability |
| RS1304839135 |
ADCY5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1304839707 |
SYK
|
Health Risk |
Likely pathogenic |
Decreased circulating immunoglobulin concentration, Arthritis |
| RS1304842966 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1304859870 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS1304867450 |
GRIK2
|
Health Risk |
Likely pathogenic |
— |
| RS1304878514 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS1304888945 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1304893896 |
CACNA1E
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1304896406 |
MCCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS1304908704 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1304915034 |
RTN4IP1
|
Health Risk |
Pathogenic |
— |
| RS1304918115 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1304952446 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1304970506 |
APC
|
Health Risk |
Pathogenic |
Gastric cancer, Gastric cancer |
| RS1304993462 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS1305000119 |
EYA4
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 10, Autosomal dominant nonsyndromic hearing loss 10 |
| RS1305005935 |
PRODH
|
Health Risk |
Pathogenic |
Proline dehydrogenase deficiency, Proline dehydrogenase deficiency |
| RS1305006253 |
POLR1C
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 11, Hypomyelinating leukodystrophy 11 |
| RS1305026083 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary diffuse gastric adenocarcinoma, Hereditary cancer-predisposing syndrome |
| RS1305041953 |
OXGR1
|
Health Risk |
Pathogenic |
Nephrolithiasis, calcium oxalate |
| RS1305053560 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, Central core myopathy |
| RS1305063593 |
SLC25A15
|
Health Risk |
Pathogenic |
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome |
| RS1305070555 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1305146157 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1305147387 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1305170860 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1305173000 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1305181844 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1305209476 |
PEPD
|
Health Risk |
Likely pathogenic |
Prolidase deficiency, Prolidase deficiency |
| RS1305222903 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1305258765 |
ERCC8
|
Health Risk |
Pathogenic |
Cockayne syndrome type 1, Cockayne syndrome type 1 |
| RS1305262063 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS1305269957 |
LIFR
|
Health Risk |
Pathogenic |
— |